Results 201 to 210 of about 213,179 (224)
Some of the next articles are maybe not open access.
Journal of Physical Chemistry B
Many enzymes are vital drug targets in diseases such as cancer and pathogenic infections; however, mutations can drastically disrupt inhibitor binding to confer resistance.
Lauren E Intravaia +5 more
semanticscholar +1 more source
Many enzymes are vital drug targets in diseases such as cancer and pathogenic infections; however, mutations can drastically disrupt inhibitor binding to confer resistance.
Lauren E Intravaia +5 more
semanticscholar +1 more source
Cancer Research
Antibody-drug conjugates (ADCs) with pyrrolobenzodiazepine (PBD) dimer payloads have been explored preclinically and several PBD-based ADCs entered clinical trials.
Anette Sommer +5 more
semanticscholar +1 more source
Antibody-drug conjugates (ADCs) with pyrrolobenzodiazepine (PBD) dimer payloads have been explored preclinically and several PBD-based ADCs entered clinical trials.
Anette Sommer +5 more
semanticscholar +1 more source
Toxic potency-adjusted control of air pollution for solid fuel combustion
Nature Energy, 2022Haotian Zheng, Qing Li, Ling Jin
exaly
Designing spatial and temporal control of vaccine responses
Nature Reviews Materials, 2021Shih Hao Ou, Wei Luo, Bali Pulendran
exaly
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
Nature Reviews Microbiology, 2020Jessa Marie V Makabenta +2 more
exaly
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models
Cell, 2020Wei Li +2 more
exaly
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency
Nature Medicine, 2018Jie Sun, Justin Eyquem, Yu-jui Ho
exaly

